Phase 1 clinical data in patients with Parkinson’s disease demonstrating reduction in endolysosomal and neuroinflammatory ...
First-ever FDA approved PROTAC supports the further development and potential of Arvinas' pipeline - - Announced FDA Approval of VEPPANU (vepdegestrant) for the treatment of ESR1m, ER+/HER2- advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results